Rheumatology Advance Access originally published online on November 8, 2005
Rheumatology 2006 45(1):112; doi:10.1093/rheumatology/kei127
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2005. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
LETTER TO THE EDITOR |
The impact of anti-TNF-
therapy on the nature of service provision
Musgrave Park Hospital, Department of Rheumatology, Belfast, UK.
Correspondence to: D. J. Armstrong. E-mail: oswald17727@hotmail.com
| The first 10% of the full text of this article appears below. |
SIR, There is accumulating evidence how the use of biological therapy might change the face of rheumatoid arthritis (RA) care, both in purely financial terms and in terms of the use of other resources [1, 2]. We believed that in our unit the most severely affected RA patients, who had previously occupied a significant number of in-patient beds and out-patient appointments, were being seen much less frequently if they were successfully established on anti-TNF therapy. We tested this hypothesis by examining the charts of all our RA patients who had